Phenotypic variability in autosomal recessive axonal Charcot-Marie-Tooth disease due to the R298C mutation in lamin A/C.

Autosomal recessive forms of axonal Charcot-Marie-Tooth (ARCMT2) disease are frequent in some areas, such as North Africa and the Middle East, since consanguineous marriages are still common there. Recently, a unique homozygous mutation in LMNA, which encodes lamin A/C, a component of the nuclear envelope, was identified in members of three Algerian families with ARCMT2 linked to chromosome 1q21.2-q21.3. In the present study we describe a group of 21 ARCMT2 patients from seven unrelated Algerian families with the same R298C mutation in the lamin A/C gene and marked variability of the clinical phenotype. There is a wide range of age of onset, from 6 to 27 years, with a mean of 14.4 +/- 4.6 years. The course of the disease varies considerably from one patient to another. Twelve patients with a disease duration of 10-15 years had a severe CMT phenotype with distal wasting and weakness of all four limbs and areflexia associated with involvement of the proximal lower limb muscles. In contrast, nine patients had the classical CMT phenotype with mild functional disability without proximal lower limb involvement after a disease duration of 5-18 years. Electrophysiological studies showed a median motor nerve conduction velocity (MNCV) in the normal range in almost all the patients. MNCV and compound muscle action potential (CMAP) values were inversely correlated with the disease duration and the MNCV was strictly related to the CMAP, strongly supporting a pure axonal process without a demyelinating component. Six patients had a nerve biopsy, which revealed severe rarefaction of myelinated fibres in all cases and an increased density of unmyelinated fibres in the majority of cases. In conclusion, the ARCMT2 associated with the R298C mutation differs from other types of ARCMT2. The variability among patients in the age of onset and the course of the disease strongly suggests the action of modifying genes, which remain to be identified.

[1]  A. Mégarbané,et al.  Phenotypic and genetic exploration of severe demyelinating and secondary axonal neuropathies resulting from GDAP1 nonsense and splicing mutations , 2003, Journal of medical genetics.

[2]  M. Ruberg,et al.  Variability of disease progression in a family with autosomal recessive CMT associated with a S194X and new R310Q mutation in the GDAP1 gene , 2003, Neuromuscular Disorders.

[3]  A. Brice,et al.  Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene. , 2003, Archives of neurology.

[4]  J. Lupski,et al.  CMT4A: Identification of a Hispanic GDAP1 founder mutation , 2003, Annals of neurology.

[5]  S. Züchner,et al.  Mutations in the ganglioside-induced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy. , 2003, Brain : a journal of neurology.

[6]  P. Sindou,et al.  The phenotypic manifestations of autosomal recessive axonalCharcot–Marie–Tooth due to a mutation in Lamin A/C gene , 2003, Neuromuscular Disorders.

[7]  C. van Broeckhoven,et al.  Mutations in GDAP1: Autosomal recessive CMT with demyelination and axonopathy , 2002 .

[8]  P. Reiss,et al.  Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy. , 2002, Neurology.

[9]  G. Scarano,et al.  Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. , 2002, American journal of human genetics.

[10]  C. Stewart,et al.  Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. , 2002, American journal of human genetics.

[11]  N. Hirokawa,et al.  Charcot-Marie-Tooth Disease Type 2A Caused by Mutation in a Microtubule Motor KIF1Bβ , 2001, Cell.

[12]  Joseph H. Nadeau,et al.  Modifier genes in mice and humans , 2001, Nature Reviews Genetics.

[13]  M. Hamida,et al.  Linkage of a new locus for autosomal recessive axonal form of Charcot–Marie–Tooth disease to chromosome 8q21.3 , 2001, Neuromuscular Disorders.

[14]  G. Sobue,et al.  An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val) , 2000, Journal of neurology, neurosurgery, and psychiatry.

[15]  B. Eymard,et al.  High Incidence of Sudden Death with Conduction System and Myocardial Disease Due to Lamins A and C Gene Mutation , 2000, Pacing and clinical electrophysiology : PACE.

[16]  O. Evgrafov,et al.  A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. , 2000, American journal of human genetics.

[17]  F. Baas,et al.  Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). , 2000, Human molecular genetics.

[18]  S. Bione,et al.  Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. , 2000, American journal of human genetics.

[19]  L. Mestroni,et al.  Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. , 2000, Circulation.

[20]  A. Brice,et al.  Autosomal recessive hereditary neuropathy with focally folded myelin sheaths and linked to chromosome 11q23: a distinct and homogeneous entity , 2000, Neuromuscular Disorders.

[21]  A. Brice,et al.  A locus for an axonal form of autosomal recessive Charcot-Marie-Tooth disease maps to chromosome 1q21.2-q21.3. , 1999, American journal of human genetics.

[22]  P. Latour,et al.  Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene , 1999, Journal of neurology, neurosurgery, and psychiatry.

[23]  M. Corey,et al.  Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13 , 1999, Nature Genetics.

[24]  F. Muntoni,et al.  Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy , 1999, Nature Genetics.

[25]  D. Claus,et al.  Autosomal recessive type II hereditary motor and sensory neuropathy with acrodystrophy , 1999, Journal of Neurology.

[26]  C. Broeckhoven,et al.  2nd Workshop of the European CMT Consortium: 53rd ENMC International Workshop on Classification and Diagnostic Guidelines for Charcot-Marie-Tooth Type 2 (CMT2–HMSN II) and Distal Hereditary Motor Neuropathy (Distal HMN–Spinal CMT) 26–28 September 1997, Naarden, The Netherlands , 1998, Neuromuscular Disorders.

[27]  A. Brice,et al.  A clinical, electrophysiologic, neuropathologic, and genetic study of two large Algerian families with an autosomal recessive demyelinating form of Charcot‐Marie‐Tooth disease , 1997, Neurology.

[28]  C. Broeckhoven,et al.  Autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths: clinical, electrophysiologic, and genetic aspects of a large family. , 1996, Neurology.

[29]  L. Tsui,et al.  Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor , 1996, Nature Genetics.

[30]  C. GilsanzFernández,et al.  [Charcot-Marie-Tooth disease, dilated myocardiopathy and cardiac conduction disorders]. , 1994 .

[31]  F. Gabreëls,et al.  Hereditary motor and sensory neuropathy of neuronal type with onset in early childhood , 1991, Clinical Neurology and Neurosurgery.

[32]  P. Pellegrino,et al.  Charcot-marie-tooth disease and cardiac arrhythmias , 1988, Brain and Development.

[33]  P. Dyck,et al.  Cardiomyopathy in patients with hereditary motor and sensory neuropathy. , 1987, Mayo Clinic proceedings.

[34]  C. Angelini,et al.  Sensory, Motor, and Autonomic Neuropathy in Patients with Multiple Symmetric Lipomatosis , 1985, Medicine.

[35]  P K Thomas,et al.  Autosomal recessive forms of hereditary motor and sensory neuropathy. , 1980, Journal of neurology, neurosurgery, and psychiatry.

[36]  P K Thomas,et al.  The clinical features of hereditary motor and sensory neuropathy types I and II. , 1980, Brain : a journal of neurology.

[37]  P. Dyck,et al.  Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. , 1968, Archives of neurology.

[38]  J. Gilbert,et al.  Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21 , 2002, Nature Genetics.

[39]  I. Marín,et al.  The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease , 2002, Nature Genetics.

[40]  N. Hirokawa,et al.  Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. , 2001, Cell.

[41]  R. Barrantes,et al.  A second locus for an axonal form of autosomal recessive Charcot-Marie-Tooth disease maps to chromosome 19q13.3. , 2001, American journal of human genetics.

[42]  R. Hegele,et al.  Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. , 2000, Human molecular genetics.

[43]  C. Gilsanz Fernández,et al.  [Charcot-Marie-Tooth disease, dilated myocardiopathy and cardiac conduction disorders]. , 1994, Anales de medicina interna.